| ID | dbAMP20431 |
|---|---|
| Sequence | FAKLLAKLAK |
| Length | 10 |
| Name | FLAK50 T1&&FLAK peptides |
| Source | FLAK peptides |
| Activity | Antibacterial |
| Pathogen | Staphylococcus aureus ATCC 6538 (MIC=50µg/ml)&&Staphylococcus aureus ATCC 25923 &&Skin Cancer (LD50 =635 µg/ml)&&Saccharomyces cerevisiae (MFC=100µg/ml)&&Pseudomonas aeruginosa ATCC 9027 (MIC=200µg/ml)&&Pseudomonas aeruginosa ATCC 27853 &&Prostate Cancer |
| Hemolytic Activity | Not included yet |
| Cytotoxicity | Not included yet |
| N-terminal Modification | Not included yet |
| C-terminal Modification | Not included yet |
| Linear/Cyclic/Branched | Not included yet |
| Uniprot | |
| PDB | |
| 3D View | |
| PDB Download | Download PDB Predicted by Alphafold2 |
| PubMed ID |
Physicochemical Properties
| Residues | 10 |
|---|---|
| Sequence | FAKLLAKLAK |
| Molecular Weight | 1102.412 |
| Grand Average of Hydropathy | 0.79 |
| Isoelectric Point | 10.302 |
| Charge at pH 7.4 | 2.55 |
| Secondary Structure | Helix: 0.400, Turn: 0.000, Sheet: 0.600 |
| Instability Index | -7.98 |
| Aromaticity | 0.1 |